Dadasaheb Balpande College of Pharmacy
The nutraceutical industry in India has experienced unprecedented growth, fuelled by increasing public interest in preventive healthcare, lifestyle modification, and consumer preference for natural, evidence-based wellness products. Despite this expansion, the regulatory environment governing nutraceuticals and dietary supplements remains intricate, evolving, and often fragmented. This review provides a systematic and critical assessment of India’s regulatory framework, with a primary focus on the Food Safety and Standards Authority of India (FSSAI) and its core regulations relevant to nutraceuticals. Key elements examined include the licensing and registration architecture, ingredient and additive governance, labelling and claims standards, and post-market compliance obligations. Current gaps such as challenges in product classification, ambiguities in the oversight of active ingredients, limited analytical infrastructure, and variable enforcement across jurisdictions are comprehensively discussed. The review also integrates international regulatory perspectives to benchmark India’s system against global best practices. Drawing from these analyses, strategic recommendations are proposed to guide regulatory harmonization, strengthen risk-based surveillance, and promote innovation while ensuring public health protection. This synthesis aims to support policymakers, industry stakeholders, and researchers in advancing a more coherent, science-driven regulatory ecosystem for nutraceuticals in India
The global nutraceutical sector has witnessed exceptional growth over the past two decades, driven by heightened public awareness of preventive healthcare, increasing prevalence of lifestyle-related disorders, and a paradigm shift from disease treatment toward wellness-oriented living. Nutraceuticals, defined as food-derived products that provide physiological or medical benefits beyond basic nutrition, encompass a diverse range of categories including vitamins, minerals, herbal extracts, antioxidants, probiotics, enzymes, amino acids, and functional foods.[1] As consumers increasingly seek natural, safe, and scientifically validated alternatives to conventional pharmaceuticals, the demand for nutraceuticals continues to rise worldwide.
India represents one of the most dynamic nutraceutical markets globally. With a population exceeding 1.4 billion, a rapidly expanding middle class, and deep cultural roots in traditional medicine systems such as Ayurveda, Siddha, and Unani, the country is uniquely positioned to lead innovation in plant-based and functional health products.[2, 3] The Indian nutraceutical industry has been growing at a compound annual growth rate (CAGR) of 12–15%, bolstered by increasing urbanization, improved access to health information, and the influence of digital marketplaces.[4, 5] Furthermore, the COVID-19 pandemic significantly accelerated the uptake of immunity-boosting supplements, micronutrient formulations, and herbal products, underscoring the role of nutraceuticals in population-level health resilience.
Despite this rapid expansion, the regulatory landscape governing nutraceuticals in India remains complex, evolving, and at times ambiguous. Nutraceuticals exist at the intersection of food and drug categories, leading to frequent classification challenges, overlapping regulatory jurisdictions, and inconsistent enforcement. Historically, food safety and quality were governed by multiple fragmented laws such as the Prevention of Food Adulteration Act, 1954; Fruit Products Order, 1955; and Milk and Milk Products Order, 1992 resulting in heterogeneity in regulatory oversight.[6, 7] The introduction of the Food Safety and Standards Act (FSS Act), 2006 represented a landmark shift, consolidating these disparate regulations into a unified framework and establishing the Food Safety and Standards Authority of India (FSSAI) as the central regulatory authority.
FSSAI has since developed a structured regulatory system for nutraceuticals through the Food Safety and Standards (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Functional Food, and Novel Food) Regulations, 2016. These regulations define product categories, outline permissible ingredients and their limits, specify manufacturing and labelling requirements, and delineate conditions for health and nutrition claims. Complementary frameworks including the Food Product Standards and Food Additives Regulations (2011), Labelling and Display Regulations (2020), Advertising and Claims Regulations (2018), and the Approval for Non-Specified Food Ingredients Regulation (2017) further guide compliance and market authorization.[8, 9]
However, several challenges persist despite these structured rules. Manufacturers often struggle with unclear boundaries between food and drug regulations, especially when products carry physiological or disease-related claims. The approval process for novel ingredients remains lengthy and data-intensive, while testing capabilities for herbal and fortified products vary across accredited laboratories. Digital marketing and e-commerce platforms have introduced additional layers of complexity, with widespread issues related to unsubstantiated health claims, misleading advertisements, and parallel imports. Moreover, nutrivigilance a critical element for monitoring post-market safety is still in its early developmental stage in India.
When benchmarked against established international systems such as the U.S. Dietary Supplement Health and Education Act (DSHEA, 1994), the European Union’s Novel Food Regulation, or Canada’s Natural Health Products Regulations, India’s regulatory framework is transitioning but not yet fully harmonized.[10] A shift toward risk-based assessment, evidence-driven ingredient approval mechanisms, and enhanced surveillance infrastructure is essential to improve consumer protection and enable responsible innovation. As the global nutraceutical market becomes increasingly competitive, aligning Indian regulations with international standards will be crucial for fostering exports, encouraging industry growth, and enhancing scientific credibility.
Given this context, a comprehensive and critical evaluation of the Indian nutraceutical regulatory ecosystem is necessary. This review aims to systematically examine the current regulatory provisions applicable to nutraceuticals in India, assess the roles of key governing bodies, evaluate compliance and licensing procedures, and identify major implementation challenges. Additionally, a comparative global perspective is provided to contextualize India’s progress and highlight opportunities for regulatory harmonization. The review concludes with strategic, evidence-based recommendations to strengthen governance, streamline approval pathways, enhance safety surveillance, and support sustainable growth of the nutraceutical sector.
2. Classification of Nutraceuticals in India
The Food Safety and Standards (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Food for Special Medical Purpose, Functional Food, and Novel Food) Regulations, 2016 provide the foundational framework for classifying nutraceuticals in India.[11] These regulations categorize products based on their source, technological development, history of consumption, and intended physiological function. As shown in Table 1, nutraceuticals are broadly divided into Traditional Nutraceuticals and Non-Traditional Nutraceuticals, each comprising multiple subcategories. A conceptual representation of this classification has been illustrated in Figure 1.
Figure 1. Classification of Nutraceuticals in India
2.1 Traditional Nutraceuticals
Traditional nutraceuticals consist of naturally occurring bioactive components that have been consumed historically as part of regular diets or traditional medicine systems. These products are derived from food sources, botanical materials, or natural metabolites, and are generally regarded as safe due to longstanding human exposure. Typical subclasses include:
These nutraceuticals are predominantly used for supporting general health, metabolic regulation, and disease-risk reduction. Their natural origin makes them a major segment of the Indian nutraceutical marketplace.
2.2 Non-Traditional Nutraceuticals
Non-traditional nutraceuticals encompass technologically advanced or scientifically engineered products that do not necessarily have a long history of consumption.[12, 13] They are developed using fortification, biotechnology, fermentation, or recombinant techniques to enhance nutritional value, stability, or targeted physiological effects. Key subclasses include:
Non-traditional nutraceuticals represent the growing integration of biotechnology into nutrition science, offering enhanced therapeutic efficacy but requiring rigorous regulatory scrutiny.
Table 1. Classification of Nutraceuticals Under FSSAI (2016 Regulations)
|
Category |
Description |
Examples |
Primary Functions |
|
Traditional Nutraceuticals |
Natural products with a history of safe use |
Vitamins, minerals, herbal extracts, enzymes, probiotics |
Antioxidant activity, metabolic support, immune enhancement |
|
Non-Traditional Nutraceuticals |
Scientifically developed or fortified products |
Vitamin-fortified foods, engineered probiotics, recombinant bioactive |
Enhanced efficacy, targeted health benefits |
3. Key Regulatory Bodies and Legislative Framework:
A coherent and scientifically governed regulatory framework is fundamental to ensuring the safety, quality, and market integrity of nutraceutical products in India. Over time, the Indian regulatory environment has transitioned from a fragmented, multi-law structure to a unified, risk-based governance model primarily overseen by the Food Safety and Standards Authority of India (FSSAI). This section provides a detailed account of the historical development of nutraceutical regulations and the pivotal role of FSSAI within the current regulatory architecture. A summary of pre-FSS Act legislation is presented in Table 2, while Figure 3 conceptually outlines the evolution of India’s modern regulatory framework.
3.1 Historical Background
Prior to the enactment of the Food Safety and Standards Act (FSS Act), 2006, India’s food safety governance was distributed across multiple legislative instruments, each focused on specific product categories.[14] Although these regulations played critical roles in ensuring product hygiene and quality within their respective domains, their fragmented nature resulted in regulatory duplication, inconsistent standards, and challenges in enforcement particularly as the food and nutraceutical industries became more scientifically complex.[15]
Key regulatory instruments operational before 2006 included:
While individually effective, these laws lacked harmonization across food categories and could not adequately regulate modern functional foods, fortified products, or bioengineered nutraceuticals. The need for an integrated, science-driven regulatory system became increasingly evident with the rapid expansion of dietary supplements and nutraceutical formulations in the early 2000s.
In response, the Food Safety and Standards Act (2006) was introduced to consolidate all existing food-related laws under a unified framework. This landmark statute established the Food Safety and Standards Authority of India (FSSAI) as the apex national body responsible for regulating all aspects of food and later, nutraceutical safety and standards. The Act signaled a shift toward a holistic, preventive, and evidence-based regulatory model aligned with international best practices.[16, 17]
Table 2. Major Pre-FSS Act Regulations Governing Food Products in India
|
Regulation |
Year |
Scope and Primary Objective |
|
Prevention of Food Adulteration Act (PFA) |
1954 |
Prevent food adulteration; establish baseline safety standards |
|
Fruit Products Order (FPO) |
1955 |
Quality control of fruit and vegetable products |
|
Meat Food Products Order (MFPO) |
1973 |
Hygiene and safety regulations for meat products |
|
Milk and Milk Products Order (MMPO) |
1992 |
Licensing and sanitary control in dairy processing |
|
Various State Food Regulations |
— |
Region-specific food safety enforcement |
3.2 Role of the Food Safety and Standards Authority of India (FSSAI)
FSSAI functions as the principal regulatory agency for nutraceuticals, health supplements, and other food products in India. Its mandate spans standard-setting, licensing, surveillance, risk communication, ingredient evaluation, and coordination with state authorities. The institution operates on a risk-based, scientific framework that reflects global regulatory principles.[18]
1. Establishment of Standards and Specifications
FSSAI formulates standards for nutraceutical ingredients, additives, processing aids, contaminants, and permissible claims. These standards are developed through expert scientific panels and harmonized with Codex Alimentarius guidelines where appropriate.
2. Licensing and Registration through FoSCoS
FSSAI regulates Food Business Operators (FBOs), including nutraceutical manufacturers, importers, and marketers, using the Food Safety and Compliance System (FoSCoS).
This ensures adherence to good manufacturing practices, hygiene standards, and ingredient safety.
3. Ingredient Approval and Risk Assessment
Under the Approval for Non-Specified Food and Food Ingredients Regulations (2017), FSSAI evaluates novel or non-specified ingredients. The evaluation process includes assessment of toxicological data, historical use, human safety studies, and manufacturing protocols.[16]
4. Regulation of Labelling, Claims, and Advertisements
FSSAI enforces compliance with the Labelling and Display Regulations (2020) and the Advertising and Claims Regulations (2018) to ensure consumer transparency and prevent misleading or exaggerated health claims.
5. Import Oversight and Surveillance
In collaboration with customs authorities, FSSAI regulates the import of nutraceuticals through port inspections, documentation checks, and laboratory testing to ensure compliance with Indian standards.
6. Coordination with State Regulatory Authorities
State Food Safety Authorities conduct inspections, sampling, enforcement actions, and audits under FSSAI’s guidance, creating a decentralized yet harmonized enforcement environment.
7. Capacity Building, Education, and Public Health Initiatives
FSSAI regularly engages in upgrading laboratory capabilities, developing guidance documents, training industry personnel, and educating consumers on safe nutraceutical use.
4. Major FSSAI Regulations Relevant to Nutraceuticals
India’s nutraceutical sector is governed by a consolidated regulatory framework established under the Food Safety and Standards Act (FSS Act), 2006.[19] This framework comprises multiple regulations that define standards for ingredients, additives, manufacturing, labelling, claims, imports, and safety surveillance. The key regulations applicable to nutraceuticals are summarized in Table 3.
4.1 Core Framework Regulations
4.1.1 Food Safety and Standards Act (2006)
The foundational legislation that consolidated earlier food laws and created the Food Safety and Standards Authority of India (FSSAI). It provides the legal basis for all subsequent nutraceutical-related regulations.
4.1.2 Food Safety and Standards Regulations (FSSR), 2011
Covers general licensing, hygiene, sanitation, and operational requirements for all Food Business Operators, including nutraceutical manufacturers and importers.
4.2 Nutraceutical-Specific Regulations
4.2.1 Health Supplements and Nutraceuticals Regulations (2016)
Defines nutraceutical categories, permissible ingredients, safety limits, and basic claims. It is the central regulation governing formulation and compliance.
4.2.2 Food Product Standards & Additives Regulations (2011)
Specifies permissible additives and their maximum limits across nutraceutical formulations.
4.2.3 Licensing & Registration Regulations (2011)
Mandates licensing norms under the FoSCoS system.
From 1 January 2022, all nutraceutical manufacturers and importers must obtain a Central FSSAI License.
4.2.4 Approval for Non-Specified Food Ingredients (2017)
Provides the approval pathway for novel or unlisted ingredients requiring safety evaluation.
4.3 Consumer Safety and Transparency Regulations
4.3.1 Contaminants, Toxins & Residues Regulations (2011)
Sets limits for heavy metals, pesticides, mycotoxins, and microbial contaminants.
4.3.2 Advertising & Claims Regulations (2018)
Prevents misleading or unsubstantiated claims, particularly therapeutic claims.
4.3.3 Labelling & Display Regulations (2020)
Mandates detailed nutritional, ingredient, and safety labelling.
4.3.4 Packaging Regulations (2018)
Ensures the use of safe, food-grade packaging materials.
4.3.5 Import Regulations (2017)
Defines procedures for importing nutraceuticals, including testing and port inspection.
Table 3. Major FSSAI Regulations Relevant to Nutraceuticals
|
Regulation |
Purpose |
|
FSS Act, 2006 |
Establishes FSSAI; unified food law |
|
FSSR, 2011 |
General licensing, hygiene, safety norms |
|
Health Supplements & Nutraceuticals Regulations, 2016 |
Ingredient standards; product definitions |
|
Food Product Standards & Additives Regulations, 2011 |
Limits and specifications for additives |
|
Licensing & Registration Regulations, 2011 |
Licensing requirements for FBOs |
|
Non-Specified Food Ingredient Approval, 2017 |
Approval of novel/innovative ingredients |
|
Contaminants, Toxins & Residues Regulations, 2011 |
Limits for contaminants |
|
Advertising & Claims Regulations, 2018 |
Control of misleading claims |
|
Labelling & Display Regulations, 2020 |
Mandatory labelling requirements |
|
Packaging Regulations, 2018 |
Standards for packaging materials |
|
Import Regulations, 2017 |
Oversight of imported nutraceuticals |
5. Licensing and Registration Requirements
Licensing and registration of nutraceutical manufacturers and importers in India are governed under the Food Safety and Standards (Licensing and Registration of Food Businesses) Regulations, 2011.[20, 21] FSSAI mandates a centralized licensing system for all nutraceutical-related Food Business Operators (FBOs) to ensure compliance with safety, hygiene, and regulatory standards.
5.1 Central Licensing Mandate (Effective from 1 January 2022)
As per FSSAI notification, all nutraceutical manufacturers and importers must obtain a Central FSSAI License, regardless of annual turnover or production capacity. This mandate ensures uniform national oversight of nutraceutical operations.
Table 4. Types of FSSAI Licenses for Nutraceutical Businesses
|
Business Type |
Regulatory Authority |
Application Form |
License Type |
|
Manufacturer |
FSSAI (Central) |
Form B |
Central License (Form C) |
|
Importer |
FSSAI (Central) |
Form B |
Import License (Form C) |
5.2 Licensing Procedure via FoSCoS
The Food Safety and Compliance System (FoSCoS) is the official online portal for issuing and managing FSSAI licenses. The licensing process is standardized and consists of the following steps:
Figure 3. Step-by-Step Workflow
Additives are incorporated into nutraceutical formulations to enhance stability, taste, appearance, shelf life, and overall product acceptability. Only additives listed under the Food Additives Regulations, 2011 are permitted. Table 6 summarizes the most commonly used additive classes in nutraceutical products.
Table 6 . Common Additives Used in Nutraceutical Formulations
|
Additive Type |
Examples |
Primary Function |
|
Antioxidants |
Ethyl gallate, Propyl gallate |
Prevent oxidation and spoilage |
|
Preservatives |
Acetic acid, Sulphur dioxide |
Inhibit microbial growth; extend shelf life |
|
Flavouring Agents |
Citric acid, Carboxymethyl cellulose (CMC) |
Improve taste and palatability |
|
Sweeteners |
Aspartame, Sucralose |
Provide sweetness without calories |
|
Colourants |
Chlorophyll, Riboflavin |
Enhance visual appearance of products |
These additives must strictly comply with FSSAI’s specified limits, purity requirements, and intended functional categories.
7. Additional Regulatory Considerations
In addition to FSSAI’s nutraceutical-specific regulations, several other legislative frameworks influence the classification, marketing, and oversight of nutraceutical products in India. These laws ensure consumer protection, prevent misleading claims, and clarify the boundary between nutraceuticals and pharmaceuticals.
7.1 Drugs and Cosmetics Act, 1940
The Drugs and Cosmetics Act (D&C Act), 1940 becomes applicable when a nutraceutical product makes therapeutic, diagnostic, or disease-treatment claims.[22] If any product is positioned as capable of treating, curing, preventing, or mitigating disease, it is reclassified as a drug, thereby requiring approval from the Central Drugs Standard Control Organization (CDSCO) rather than FSSAI. This distinction is crucial for maintaining the regulatory separation between foods and pharmaceuticals.
7.2 Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954
This Act prohibits false, exaggerated, or misleading health claims, especially those related to the treatment of critical or incurable diseases. It restricts advertisements that could exploit vulnerable consumers and ensures truthful communication of product benefits. Nutraceutical manufacturers must ensure that marketing practices strictly comply with this Act to avoid penal action.
7.3 State Drug Control Regulations
State Drug Control Authorities play an important role in:
In cases where the classification between a nutraceutical and a drug is ambiguous, state drug inspectors may intervene to assess compliance and determine the appropriate regulatory pathway. This reinforces consistency between national food laws and state-level drug regulations.
FUTURE PROSPECTS
India’s nutraceutical sector holds significant potential for expansion, innovation, and global leadership. As consumer preferences shift toward preventive and nutrition-based healthcare, the demand for high-quality nutraceutical products is expected to rise steadily. The integration of modern scientific tools such as biotechnology, metabolomics, and advanced analytical chemistry with India’s rich heritage of traditional medicine presents a unique opportunity to develop differentiated and clinically supported nutraceutical formulations.
Future growth will depend heavily on the evolution of a science-driven, harmonized regulatory ecosystem. Strengthening evidence requirements, standardizing botanical and bioactive ingredients, and improving post-market surveillance will enhance product credibility and consumer trust. In addition, advances in personalized nutrition, microbiome research, and precision supplementation are likely to shape the next generation of nutraceutical products, enabling targeted health benefits and improved therapeutic outcomes.
Digital marketplaces and e-commerce platforms are also expected to play a pivotal role in expanding market access. However, this will require robust monitoring systems to address misleading claims and ensure regulatory compliance in the online environment. Investment in high-quality research, clinical studies, and nutrivigilance systems will be essential to support science-backed innovation and international market acceptance.
The global nutraceutical market is projected to grow substantially, and India is well-positioned to emerge as a competitive exporter of functional foods, herbal formulations, probiotics, and novel bioactives. Strengthening collaborations among academia, industry, and regulatory bodies will facilitate innovation, capacity building, and knowledge exchange. With improved regulatory clarity, upgraded laboratory infrastructure, and increased emphasis on product standardization, India can transform into a global hub for safe, effective, and scientifically validated nutraceuticals.
CONCLUSION
The Indian nutraceutical industry is undergoing rapid expansion, driven by increasing consumer awareness of preventive healthcare, rising lifestyle-related disorders, and growing reliance on natural health products. Despite this promising trajectory, the regulatory landscape remains complex, with persistent challenges related to product classification, ingredient approvals, labelling compliance, and enforcement consistency across jurisdictions. The Food Safety and Standards Authority of India (FSSAI) has made substantial progress in establishing comprehensive regulations, yet further refinement is required to align national standards with global best practices.
A unified, science-based, and risk-oriented regulatory framework is essential to ensure product safety, enhance consumer trust, and support innovation in the nutraceutical sector. Strengthening clarity in regulatory definitions, improving evidence requirements for novel ingredients, expanding laboratory capacity, and reinforcing post-market surveillance will be vital to achieving these goals. As the sector continues to evolve, collaborative efforts between industry, academia, and regulatory bodies will play a crucial role in enabling India to fully realize the potential of nutraceuticals in public health and economic growth.
REFERENCES
Sachin Patil Takle, Dr. Ujwala Mahajan, Regulatory Landscape of Nutraceuticals in India: Current Status, Challenges, and a Roadmap for Harmonization, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 5, 4880-4890, https://doi.org/10.5281/zenodo.20284587
10.5281/zenodo.20284587